Effect of Hepatic Impairment on the Pharmacokinetics of Pasireotide (SOM230): Results From a Multicenter Phase I Study
Yves Horsmans(Cliniques Universitaires Saint-Luc), Douglas M. Heuman, Ke Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Dongweon Song(Novartis (Switzerland)), Ying Wang(Shanghai University of Traditional Chinese Medicine), Yanfeng Wang(Wuhan University), Matthieu Ruffin(Novartis (Switzerland)), Emmanuel Bouillaud(Novartis (Switzerland)), F J Botha, Dago Mazur(PAREXEL International (United Kingdom))
Cited by 9
Related Papers
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
|The Journal of Clinical Endocrinology & Metabolism|2014|394
High-dimensional pattern regression using machine learning: From medical images to continuous clinical variables
|NeuroImage|2010|182
Optimized Feature Extraction for Learning-Based Image Steganalysis
|IEEE Transactions on Information Forensics and Security|2007|173
Human Activity Recognition Based on R Transform
|Unknown|2007|161